The CIGBS Adisory Board members are experienced in world health issues and will guide the center's projects and initiatives.
Prior to his consulting career, Stephen Becker led the HIV prevention and treatment efforts at the Bill & Melinda Gates foundation. His work included activities related to HIV “cure” (sustained remission), the interface between family planning, reproductive biology and HIV, as well as the comprehensive biome in HIV disease. Becker also has worked in the biotechnology sphere where he served as CMO, and led early phase development programs for innovative HIV therapeutics.
At UCSF in the early 1980s, Becker led a large HIV clinical practice and clinical research program with research including pharmacology and pharmacogenetics, early stage drug development and HIV health service outcomes.
Becker was a Robert Wood Johnson Clinical Scholar at the joint UCSF-Stanford program, prior to joining the USCF faculty. He completed his internal medicine training at Cook County Hospital; is a graduate of the Jacobs School of Medicine and Biomedical Sciences and the University of Pennsylvania.
Mark Bruns has extensive experience in the clinical diagnostics and medical device markets. He joined Waters in 2009 to lead the clinical diagnostics business initiative and currently serves as a senior director of strategy. Previously, he was chief clinical officer and strategy leader for Waters Health Sciences Initiative, leading an effort to bring novel, real time pathology tools to intraoperative guided surgery.
Bruns also held several senior management roles at Abbott Diagnostics, managing worldwide commercial and business development activities for a $3.5B medical device portfolio. His emphasis was on market and product development for Abbott’s infectious disease franchise and novel physiological biomarkers for the clinical diagnostics market.
He holds a PhD in Chemistry from the University of Illinois at Urbana-Champaign (under the direction of Professor Larry R. Faulkner) and a BS from Valparaiso University.
Domanico is the senior director of research and development at the Clinton Health Access Initiative. He supervises development and tech transfer of better and less expensive chemistries, formulations, and fixed-dose combination products for adults and children; treatment optimization through the development, regulatory filing and quality assessment of new products, diagnostics and devices; clinical guidance on managing diseases and new treatments; generation of evidence using methodologies such as operations research, health economics and epidemiology to optimize the work of healthcare providers and improve patient outcomes; and technologies and tools that advance our understanding of disease and support CHAI’s mission to transform global health.
In 2007, Domanico founded Innovalyst: a life sciences consulting company that catalyzes product development and commercialization in diagnostics and devices, drug discovery and development, and life science informatics. From 2007-2012, Domanico led Innovalyst’s business operations and grew the corporation into a multi-million dollar international enterprise.
From 2001-2007, he was the vice president of technology development at GlaxoSmithKline (GSK) where his departments delivered and commercialized R&D technologies, assessed new investment opportunities, and designed future scenarios for the pharmaceutical industry. Domanico created the industry’s first technology accelerator for early-stage companies that combined GSK’s formidable industrial expertise and infrastructure with external investment.
Domanico holds a PhD in Chemistry and a bachelor's degree from Penn State University. He received his post-doctoral training in Molecular Biophysics at E.I. du Pont de Nemours and Co.
Sharon Hrynkow's career as a neuroscientist and global health leader spans more than 20 years in the public and private sectors. She was the inaugural president of the Global Virus Network, a non-profit organization working to prevent the spread of viral disease, including pandemic threats (2012 - 2015). Her career in public service includes over a decade of senior executive leadership roles at the National Institutes of Health, including as deputy director, Fogarty International Center (2000 - 2007), acting director of Fogarty (2004 - 2006), associate director of the National Institute of Environmental Health Sciences (2007 - 2008) and counselor and senior advisor for science at the U.S. Department of State (2010 - 2012).
Hrynkow has developed and launched innovative programs and policies on a range of global health issues, including AIDS, emerging diseases, chronic disease and public health impacts of climate change. She has worked at the highest levels with government partners and launched innovative programs to train tomorrow's health leaders worldwide. She currently serves as senior vice president for Medical Affairs at CTD Holdings, a publicly traded company, where she leads the clinical trial program to bring to market a drug against a rare and fatal disease. She is director of Forward Industries.
Hrynkow is an elected member of the Council on Foreign Relations and an elected fellow of the American Association for the Advancement of Science.
Prior to CUGH, Keith Martin served as a Member of Parliament in Canada and was appointed in 2004 to the Queen’s Privy Council for Canada. As a parliamentarian, he created CanadaAid.ca, an online platform to facilitate partnerships between universities, governments, multilateral institutions, NGOs and the private sector.
Martin has been on numerous diplomatic missions to areas in crisis including Sudan, Zimbabwe, Mali, Niger, Sierra Leone, Colombia and the Middle East. He has traveled widely in Africa and served as a physician in South Africa on the Mozambique border during that country’s civil war. He is the author of more than 150 editorial pieces published in Canada's major newspapers and has appeared frequently as a political and social commentator on television and radio. From 1997-2000, he created and moderated the nationally syndicated, current affairs television program "Beyond Politics." He is currently a board member of the Jane Goodall Institute, editorial board member for the "Annals of Global Health" and an advisor for the International Cancer Expert Corps. He has contributed to the Lancet Commission on the Global Surgery Deficit, is a current commissioner on the Lancet-ISMMS Commission on Pollution, Health and Development and is a member of the Global Sepsis Alliance.
Martin’s main areas of focus are in global health, foreign policy, security, international development, conservation and the environment. He is particularly interested in strengthening human resources capabilities and scaling up initiatives in low-income settings that improve environmental sustainability and human security.
David Ripin oversees CHAI’s work on increasing access to medicines and diagnostics for HIV, malaria, tuberculosis and other disease areas through the use of sustainable market interventions. CHAI’s Access program has successfully implemented agreements with pharmaceutical companies to lower the price of key drugs and diagnostics by up to 80 percent, among other achievements. Ripin also oversees the strategy and work of CHAI’s Malaria program.
Ripin joined CHAI in 2007 to lead its Pharmaceutical Sciences Team in conducting research and development work. The team worked on reducing the cost of key drugs through formulation, manufacturing and sourcing improvements, as well as conducting the transfer of these processes to manufacturing partners.
Ripin is actively involved in setting international priorities for HIV drug optimization work, organizing the "Conference on Antiretroviral Drug Optimization" in 2009. Before joining CHAI, he worked at Pfizer, Inc. for 10 years as part of the R&D group, focusing on the commercialization and manufacturing of drug candidates.
Ripin received his bachelor's degree in Chemistry and Asian Studies from Washington University in St. Louis and his PhD in Chemistry from Harvard University.
Michael T. Mbizvo is the Zambia Country Director for Population Council, which he joined in 2014, covering the SADCC region and is also employed as a professor at the College of Health Sciences, University of Zimbabwe.
Mbizvo was the director of the World Health Organization’s Department of Reproductive Health Research (RHR) from 2009-2013, holding multiple WHO positions previous to this. As director, he led a co-sponsored UNDP/UNICEF/ UNFPA/WHO/World Bank Special Program for Research, Development and Research Training in Human Reproduction. Mbizvo has played a key role in advancing reproductive health and research capacity within the international development agenda, which has included development and implementation of innovative approaches to improve reproductive health globally, in particular in low and medium-income countries.
As a professor in he University of Zimbabwe Department of Obstetrics and Gynecology, he supervises and mentors post-graduate and medical students while implementing research to improve sexual and reproductive health and prevent HIV. He also co-founded the Wits University SRH/HIV and Gender course, which trains postgraduates from across Africa. He has presented hundreds of scientific papers and published widely in the fields of sexual and reproductive health, and HIV/AIDS, including three books.
Mbizvo comes from Zimbabwe. He did prostgraduate training in the U.S. at the Jones Institute for Reproductive Medicine, Eastern Virginia Medical School. He also trained in Australia at Monash University and Prince Henry Institute of Reproductive Medicine, in Ireland at Galway University, and in Sweden at Umea University.
Tungamirirai Simbini is a trained medical doctor with post graduate qualifications in Health Informatics and Information Systems. He has a BSc and MBChB degrees from the University of Zimbabwe. He has a Master of Science in Health Informatics from Oregon Health & Sciences University, U.S.
Simbini has experience in Health Management Information Systems spanning 16 years at national and regional levels. He currently is a lecturer in Health Informatics at Africa University. He is the Principal Investigator for the Zimbabwe Human Resources Information Systems project supported by the Centers for Disease Control (CDC). Simbini consults for the Republic of Malawi's Health Management Information Systems. He also is running a private company that develops software solutions in the health sector.
Simbini is currently studying enterprise architectures for ways to improve the exchange of health information. He mentors university students in health informatics.
Jane Kengeya-Kayondo is a medical doctor with a Master’s degree in epidemiology and a Diploma in Public Health with over 30 years’ experience in health research, research coordination and research capacity strengthening.
Kengeya-Kayondo has worked for over 15 years at the World Health Organization in Tropical and infectious Diseases Research coordination and leadership positions. Kengeya-Kayondo has served the Wellcome Trust as the Special Advisor for Africa (current) and with the Africa Research Excellence Fund(AREF) as the Regional Coordinator, East & Southern Africa (current on secondment from the Wellcome Trust).
Kengeya-Kayondo has published many scientific papers and led the production of several WHO publications. Her autobiography “The Hero Within” published in 2014 is highly sought after in Africa and globally.